PATENT CLAIM ANALYSIS

Application Number: 15960488
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "005300"]

Abstract:
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.

Claim (Index 3):
A method for reducing glucose excursion in a patient with type 2 diabetes mellitus comprising administering to the patient in need thereof a therapeutically effective amount of a pharmaceutical combination comprising:\n (a) lixisenatide or a pharmaceutically acceptable salt thereof, and (b) insulin glargine or a pharmaceutically acceptable salt thereof, wherein prior to or at the onset of administration of the pharmaceutical combination the patient has a glucose excursion of at least 5 mmol/L after treatment with basal insulin; and wherein the administration of the pharmaceutical combination reduces the glucose excursion of the patient in need thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13467707', '13467757', '15237285', '14965586', '14781857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.726953382962016
- 35 USC 102 Novelty (BERT): 0.6424136593272635
- Combined Prediction Score: 0.7184994105985407
- Mean Citation Score: 590.4822740000002
- Max Citation Score: 740.9411
- Similarity Product: 553.7503521715045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test